CTOs on the Move

Medical Practice Innovations

www.mpimed.com

 
Medical Practice Innovations is a Brooklyn, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mpimed.com
  • 260 Ainslie St
    Brooklyn, NY USA 11211
  • Phone: 718.388.1600

Executives

Name Title Contact Details

Similar Companies

Arivale

Arivale is a scientific wellness company that leverages cutting-edge research, personalized data and tailored coaching to help people optimize wellness and aid in avoiding disease. Arivale provides clients a scientific path to wellness based on their unique genetic makeup, characteristics, and lifestyle. Arivale is backed by leading scientists and investors with a strong track record in health, wellness, biotech breakthroughs and in building top-tier consumer brands.

Bethesda Lutheran Communities

Bethesda is a nonprofit Christian organization that provides homes and other services for people with intellectual and developmental disabilities. Bethesda`s over 3,000 dedicated employees, volunteers and direct support professionals provide residential and supported-living services and religious assistance to nearly 2,000 adults with developmental disabilities. For more than 110-years, Bethesda has been devoted to the mission of providing person-centered care and support for people with intellectual and developmental disabilities.

Microfil

Microfil LLC is a Bridgman, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.

Johnson and Johnson Health Care Systems

Johnson & Johnson Health Care Systems Inc. (JJHCS) provides contracting, supply chain, business services, and strategic solutions to customers and commercial intermediaries of U.S.-based Johnson & Johnson (J&J) companies, including hospital systems, health plans, distributors, wholesalers, purchasing organizations, government payer programs, and government healthcare institutions in the U.S. JJHCS also engages with customers to provide streamlined supply chain services for our products that seamlessly integrate with customer operations, address shared evolving market challenges to value-based care, and develop innovative solutions that improve patient care and access.